From the Co-Editor

Louis F. Rose, DDS, MD

Dear Readers,

As oral healthcare providers, we face a myriad of new technologies and issues that challenge us as we strive to nurture our relationships with patients and provide the highest quality of care. Putting all this into focus is one of Compendium’s fortes: This month’s issue illustrates our commitment to you with a diversity of compelling topics.

For your continuing education (CE) credits, we present a thorough literature review on the popular drug classes nonsteriodal antiinflammatory drugs and selective serotonin reuptake inhibitors. Taken concomitantly, these drug classes may increase the risk for gastrointestinal bleeding, a significant concern of practitioners.

In our second CE offering, you will read about three case reports focusing on autogenous bone grafts—the gold standard. Autogenous bone grafts can be problematic: You’ll learn about new commercially available allograft materials that have similar success rates with minimum sequelae.

In addition to our continuing education articles, this month features an in-depth report exploring the use of specially designed software and models that enable surgeons to “virtually” place implants and to use surgical guides. This can be a highly effective clinical adjunct for developing successful treatment plans and predicting outcomes.

Finally, we present the latest studies on awareness in dental patients and dental professionals regarding the link between diabetes and periodontal disease. This is an insightful and useful review to help enhance your practice.

In addition, we are pleased to announce that the print edition of Compendium is available in a digital format on our Web site. You can click through the entire journal from cover to cover. The archives and the current issue can be found at https://www.compendiumlive.com/archive.php.

I think you will thoroughly enjoy this issue, and I hope you will share your comments. We welcome opportunities to continue to meet your needs and expectations. I can be reached at lrose@aegiscomm.com.

Sincerely,

Louis F. Rose, DDS, MD